Famotidine Powder, For Suspension
Product Images NDC 59651-701

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 59651-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (40 mg/5 mL (50 mL Bottle))

Label for Famotidine oral suspension, USP 40 mg/5 mL powder for suspension by Aurobindo Pharma Limited. The 50 mL bottle is to be reconstituted before dispensing, containing 40 mg famotidine per 5 mL of suspension. The label provides directions for reconstitution, inactive ingredients, storage instructions, and distributor information.*

FDA Label Image

Str (Famotidine Str)

Chemical structure diagram of famotidine, showing its molecular arrangement including amine groups, a thiazole ring, and sulfonamide moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.